发明授权
- 专利标题： Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders
- 专利标题（中）： 药物包含用于治疗炎症性疾病的还原性烷基糖单体
-
申请号： US12559107申请日： 2009-09-14
-
公开(公告)号： US09163049B2公开(公告)日： 2015-10-20
- 发明人: Jean-Philippe Houlmont , Isabelle Rico-Lattes , Emile Perez , Pascal Bordat
- 申请人： Jean-Philippe Houlmont , Isabelle Rico-Lattes , Emile Perez , Pascal Bordat
- 申请人地址： FR Boulogne-Billancourt FR Paris
- 专利权人： PIERRE FABRE DERMO-COSMETIQUE,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
- 当前专利权人： PIERRE FABRE DERMO-COSMETIQUE,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
- 当前专利权人地址： FR Boulogne-Billancourt FR Paris
- 代理机构： Birch, Stewart, Kolasch & Birch, LLP
- 优先权： FR0312798 20031031
- 主分类号： C07H15/04
- IPC分类号： C07H15/04 ; A61K31/7004 ; A61K31/7028 ; C07H3/02 ; A61K8/60 ; A61Q19/08
摘要：
The invention relates to a medicament comprising at least one reducing alkyl-sugar monomer having a hydroxyl function which is substituted by an alkoxy radical at C2-C40, said medicament being preferably intended to regulate inflammatory mechanisms. The reducing sugar is preferably selected from the group containing rhamnose, fucose and glucose. The invention also relates to a cosmetic treatment method involving the topical application of a composition comprising at least one reducing alkyl-sugar monomer having a hydroxyl function which is substituted by an alkoxy radical at C2-C40.
公开/授权文献
信息查询
IPC分类:
